Abstract
The increase in life expectancy of people with cystic fibrosis (pwCF) has come with new comorbidities, particularly diabetes. Cystic fibrosis related diabetes is a major challenge in the care of (pwCF) because it is a morbidity and mortality factor at all stages of the disease. Early glucose tolerance abnormalities observed from childhood are also associated with a poor pulmonary and nutritional outcome. This justifies systematic screening with an annual oral glucose tolerance test (OGTT) from the age of 10 years.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
